Literature DB >> 20827315

Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis.

Subir R Maitra1, Asha Jacob, Mian Zhou, Ping Wang.   

Abstract

Previous studies demonstrated that hepatic matrix metalloproteinase-9 (MMP-9) activity increased following cecal ligation and puncture (CLP) in rats, indicating liver injury in sepsis. The activity of MMP-9 in degrading extracellular matrix is controlled by activation of proenzymes and inhibition of tissue inhibitor of MMPs (TIMP-1). To further assess the proteolytic cascade imbalance in sepsis, hepatic MMP-9 and TIMP-1 expressions were examined in CLP rats. In this study, sepsis was induced in rats by CLP, and at 10 and 20 h after sepsis induction, liver samples were collected and MMP-2, MMP-9, and TIMP-1 gene and protein expressions were evaluated by real time PCR and Western blot analysis, respectively. Gene expression of MMP-9 was increased by 6.4-fold and 3.0-fold at 10 h and 20 h after CLP as compared to sham group, respectively. Likewise, MMP-9 protein expression was also significantly increased at both time points. In contrast, MMP-2 gene expression was not altered at 10 h and 20 h after CLP as compared to sham controls. Interestingly, TIMP-1 gene expression was elevated to 89-fold and 46-fold from sham levels at 10 h and 20 h after CLP, respectively. Similarly, TIMP-1 protein levels were also significantly increased at both time points. In addition, MMP-9/TIMP-1 protein ratio was lower at both 10 h and 20 h after CLP compared to sham rats. Results demonstrated an imbalance between MMP and TIMP, with a more evident role for MMP-9 than MMP-2, and high value of TIMP-1 was particularly evident in CLP rats. Our results indicate that MMP-9 and TIMP-1 expressions are increased and they may serve as useful markers to predict the outcome of sepsis.

Entities:  

Keywords:  MMP; MMP-2; MMP-9/TIMP-1 ratio; TIMP-1; inhibitors; liver; matrix metalloproteinase; sepsis

Year:  2010        PMID: 20827315      PMCID: PMC2929943     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

Review 1.  Gelatinase B: a tuner and amplifier of immune functions.

Authors:  G Opdenakker; P E Van den Steen; J Van Damme
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

2.  Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment.

Authors:  T Nakamura; I Ebihara; N Shimada; H Shoji; H Koide
Journal:  Am J Med Sci       Date:  1998-12       Impact factor: 2.378

Review 3.  The interdependence of lung antioxidants and antiprotease defense in ARDS.

Authors:  J E Gadek; E R Pacht
Journal:  Chest       Date:  1996-12       Impact factor: 9.410

Review 4.  Matrix metalloproteinases and their inhibitors in tumour growth and invasion.

Authors:  V M Kähäri; U Saarialho-Kere
Journal:  Ann Med       Date:  1999-02       Impact factor: 4.709

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

Review 6.  The family of matrix metalloproteinases.

Authors:  J F Woessner
Journal:  Ann N Y Acad Sci       Date:  1994-09-06       Impact factor: 5.691

7.  Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.

Authors:  Tobias Keck; James H Balcom; Carlos Fernández-del Castillo; Bozena A Antoniu; Andrew L Warshaw
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

8.  Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.

Authors:  Ursula Hoffmann; Thomas Bertsch; Eszter Dvortsak; Claudia Liebetrau; Siegfried Lang; Volker Liebe; Guenter Huhle; Martin Borggrefe; Martina Brueckmann
Journal:  Scand J Infect Dis       Date:  2006

9.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.

Authors:  Jay Steinberg; Jeffrey Halter; Henry J Schiller; Monica Dasilva; Steve Landas; Louis A Gatto; Paivi Maisi; Timo Sorsa; Minna Rajamaki; Hsi-Ming Lee; Gary F Nieman
Journal:  J Surg Res       Date:  2003-05-15       Impact factor: 2.192

View more
  9 in total

1.  Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection.

Authors:  Lin Teng; Min Yu; Jun-ming Li; Hua Tang; Jing Yu; Li-hua Mo; Jing Jin; Xian-zhe Liu
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

Review 2.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

3.  Synthesis and Validation of a Hydroxypyrone-Based, Potent, and Specific Matrix Metalloproteinase-12 Inhibitor with Anti-Inflammatory Activity In Vitro and In Vivo.

Authors:  J Aerts; R E Vandenbroucke; R Dera; S Balusu; E Van Wonterghem; L Moons; C Libert; W Dehaen; L Arckens
Journal:  Mediators Inflamm       Date:  2015-08-13       Impact factor: 4.711

4.  Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study.

Authors:  Miaomiao Wang; Qian Zhang; Xin Zhao; Guijuan Dong; Chunsheng Li
Journal:  Crit Care       Date:  2014-11-19       Impact factor: 9.097

5.  Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock.

Authors:  Margaret R Passmore; Liam Byrne; Nchafatso G Obonyo; Louise E See Hoe; Ai-Ching Boon; Sara D Diab; Kimble R Dunster; Kavita Bisht; John-Paul Tung; Mohd H Fauzi; Monica Narula; Sanne E Pedersen; Arlanna Esguerra-Lallen; Gabriela Simonova; Annette Sultana; Chris M Anstey; Kiran Shekar; Kathryn Maitland; Jacky Y Suen; John F Fraser
Journal:  Respir Res       Date:  2018-11-22

6.  Early Protein Markers of Necrotizing Enterocolitis in Plasma of Preterm Pigs Exposed to Antibiotics.

Authors:  Yan-Nan Jiang; Tik Muk; Allan Stensballe; Duc Ninh Nguyen; Per Torp Sangild; Ping-Ping Jiang
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

7.  MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.

Authors:  Ann Kristin Barton; Ina-Gabriele Richter; Tanja Ahrens; Roswitha Merle; Abdollah Alalwani; Svenja Lilge; Katrin Purschke; Dirk Barnewitz; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2021-01-05       Impact factor: 4.711

8.  Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study.

Authors:  Nicola Fiotti; Filippo Mearelli; Filippo Giorgio Di Girolamo; Luigi Mario Castello; Alessio Nunnari; Salvatore Di Somma; Enrico Lupia; Efrem Colonetti; Maria Lorenza Muiesan; Giuseppe Montrucchio; Carlo Giansante; Gian Carlo Avanzi; Gianni Biolo
Journal:  Biomolecules       Date:  2022-02-09

9.  The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients.

Authors:  Bastian Lubis; Aznan Lelo; Putri Amelia; Agus Prima
Journal:  Infect Drug Resist       Date:  2022-09-30       Impact factor: 4.177

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.